[1]Dalbayrak S, Yaman O, Yilmaz T. Current and future surgery strategies for spinal cord injuries[J]. World J Orthop, 2015, 6(1): 34-41.
[2]Garcia E, Aguilar-Cevallos J, Silva-Garcia R, et al. Cytokine and growth factor activation in vivo and in vitro after spinal cord injury[J]. Mediators Inflamm, 2016, 2016:9476020.
[3]Ding L, Wendl MC, Koboldt DC, et al. Analysis of next-generation genomic data in cancer: accomplishments and challenges[J]. Hum Mol Genet, 2010, 19(R2): R188-196.
[4]Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats[J]. J Neurotrauma, 1995, 12(1): 1-21.
[5]Kabu S, Gao Y, Kwon BK, et al. Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury[J]. J Control Release, 2015,10(219):141-154.
[6] Liu XD,Xue ChB, Ju QQ, et al. Repair of spinal cord injury by using the tissue engineered nervegraftsconstructed by silk fibroin /filament including seed cells[J]. Acta Anatomica Sinica, 2015,46(5):596-601.(in Chinese)
刘晓东, 薛成斌, 鞠前前, 等. 含种子细胞的丝素组织工程神经移植物修复大鼠脊髓损伤[J]. 解剖学报, 2015, 46(5):596-601.
[7]Xu JW, Han Sh, Ling ShC.The expression of regeneration gene protein 2 in the spinal cord traverse injury model[J]. Acta Anatomica Sinica, 2008, 39(4):454-459.(in Chinese)
徐纪伟, 韩曙,凌树才.脊髓横断损伤后再生基因蛋白的表达[J]. 解剖学报, 2008,39(4):454-459.
[8]Zhao W, Huang X, Zhang L, et al. Penehyclidine hydrochloride pretreatment ameliorates rhabdomyolysis-induced AKI by activating the Nrf2/HO-1 pathway and allevi-ating endoplasmic reticulum stress in rats[J]. PLoS One, 2016, 11(3): e0151158.
[9]Agarwal A, Bolisetty S. Adaptive responses to tissue injury: role of heme oxygenase-1[J]. Trans Am Clin Climatol Assoc, 2013, 124(1)111-122.
[10]Agundez JA, Garcia-Martin E, Martinez C, et al. Heme oxygenase-1 and 2 common genetic variants and risk for multiple sclerosis[J]. Sci Rep, 2016, 6:20830.
[11]Hayashi G, Cortopassi G. Lymphoblast oxidative stress genes as potential biomarkers of disease severity and drug effect in friedreich’s ataxia[J]. PLoS One, 2016, 11(4): e0153574.
[12]Savchenko VL. Regulation of NADPH oxidase gene expression with PKA and cytokine IL-4 in neurons and microglia[J]. Neurotox Res, 2013, 23(3): 201-213.
[13]Riemenschneider M, Konta L, Friedrich P, et al. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer’s disease[J]. Hum Mol Genet, 2006, 15(16): 2446-2456.
[14]Meiri N, Masos T, Rosenblum K, et al. Overexpression of urokinase-type plasminogen activator in transgenic mice is correlated with impaired learning[J]. Proc Natl Acad Sci USA, 1994, 91(8): 3196-3200.
[15]Xu Y, Cheng X, Cui X, et al. Effects of 5-h multimodal stress on the molecules and pathways involved in dendritic morphology and cognitive function[J]. Neurobiol Learn Mem, 2015, 123:225-238.
[16]Liang Q, De Windt LJ, Witt SA, et al. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo[J]. J Biol Chem, 2001, 276(32): 30245-30253.
[17]Kutz SM, Higgins CE, Higgins PJ. Novel combinatorial therapeutic targeting of PAI-1 (SERPINE1) gene expression in Alzheimer’s disease[J]. Mol Med Ther, 2012, 1(2): 106.
[18]Fabbro S, Schaller K, Seeds NW. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer’s disease transgenic mouse model[J].J Neurochem, 2011, 118(5): 928-938.
[19]Pelisch N, Dan T, Ichimura A, et al. Plasminogen activator inhibitor-1 antagonist TM5484 attenuates demyelination and axonal degeneration in a mice model of multiple sclerosis[J]. PLoS One, 2015, 10(4): e0124510.
[20]Ahmed Z, Bansal D, Tizzard K, et al. Decorin blocks scarring and cystic cavitation in acute and induces scar dissolution in chronic spinal cord wounds[J]. Neurobiol Dis, 2014, 64:163-176.
|